Bausch Health Companies Inc.
BHC.TO
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -11.91% | 1.85% | |||
| Total Other Revenue | 3.23% | 10.71% | |||
| Total Revenue | -11.72% | 1.95% | |||
| Cost of Revenue | -3.58% | 4.45% | |||
| Gross Profit | -14.96% | 0.99% | |||
| SG&A Expenses | 5.64% | -4.00% | |||
| Depreciation & Amortization | -1.16% | -5.47% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.27% | -0.05% | |||
| Operating Income | -54.71% | 9.19% | |||
| Income Before Tax | -122.49% | 1,095.24% | |||
| Income Tax Expenses | -64.86% | 56.34% | |||
| Earnings from Continuing Operations | -187.76% | 206.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 660.00% | -171.43% | |||
| Net Income | -162.37% | 209.41% | |||
| EBIT | -54.71% | 9.19% | |||
| EBITDA | -36.29% | 4.04% | |||
| EPS Basic | -162.76% | 208.37% | |||
| Normalized Basic EPS | -103.92% | 8.56% | |||
| EPS Diluted | -162.76% | 208.37% | |||
| Normalized Diluted EPS | -103.92% | 8.56% | |||
| Average Basic Shares Outstanding | -0.65% | 0.98% | |||
| Average Diluted Shares Outstanding | -0.65% | 0.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||